Eptifibatide After PCI: Brief Infusion Is Just As Good

AudioMedica News
AudioMedica News
Eptifibatide After PCI: Brief Infusion Is Just As Good
Loading
/
Anthony Fung
Anthony Fung
REFERENCE: Late Breaking Clinical Trials Session I, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
ANTHONY FUNG, University of British Columbia, Vancouver
Brief courses of antiplatelet therapy with the glycoprotein 2b 3a inhibitor are just as effective as longer infusions for patients receiving non-emergency percutaneous intervention. So said Anthony Fung at the first session of Late breaking Clinical Trials held at the American Heart Association’s annual meeting in Orlando. He talked with Peter Goodwin about his findings.

[audio:https://www.audiomedica.com/podcasting/cardio/071104AnthonyFungPODCAST.mp3]

Further reading

Sign up for AudioMedica.com news

* = required field
Speciality